Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_3
5
45%
Ph phase_2
3
27%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

3

Mid Stage

8

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
5(45.5%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 35 (45.5%)
Phase 43 (27.3%)

Trials by Status

not_yet_recruiting19%
recruiting19%
unknown218%
completed764%

Recent Activity

1 active trials
Showing 5 of 11
not_yet_recruitingphase_2

Mast Cell Treatment in Post-tick Bite Illness (PTBI)

NCT07526558
completedphase_4

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

NCT05616442
recruitingphase_3

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

NCT02484248
completedphase_3

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

NCT00769886
completedphase_3

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

NCT00770133
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07526558Phase 2

Mast Cell Treatment in Post-tick Bite Illness (PTBI)

Not Yet Recruiting
NCT05616442Phase 4

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

Completed
NCT02484248Phase 3

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

Recruiting
NCT00769886Phase 3

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

Completed
NCT00770133Phase 3

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

Completed
NCT01902017Phase 2

Investigations of Mechanisms and Treatment in Post-traumatic Joint Contractures

Completed
NCT01553318Phase 3

Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study

Completed
NCT02673840Phase 4

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever

Unknown
NCT01625715Phase 2

Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization

Unknown
NCT00133627Phase 4

Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis

Completed
NCT00639587Phase 3

Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11